Skip to main content
Livermore
Livermore
ZHEN

STRS Ohio

SEC CIK
0000820478
Latest filing
Jul 30, 2026

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by STRS Ohio, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings

Shares (Q2 2026)
15,100
Value
$1.85M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PTGX by STRS Ohio, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,100$1.85M<0.1%−300−1.9%ReducedHolders
Q1 202615,400$1.62M<0.1%−500−3.1%ReducedHolders
Q4 202515,900$1.39M<0.1%−1,900−10.7%ReducedHolders
Q3 202517,800$1.18M<0.1%−1,800−9.2%ReducedHolders
Q2 202519,600$1.08M<0.1%+600+3.2%AddedHolders
Q1 202519,000$918.8K<0.1%−4,500−19.1%ReducedHolders
Q4 202423,500$907.1K<0.1%+2,000+9.3%AddedHolders
Q3 202421,500$967.5K<0.1%−3,400−13.7%ReducedHolders
Q2 202424,900$862.8K<0.1%+23,000+1,210.5%AddedHolders
Q1 20241,900$54.0K<0.1%−500−20.8%ReducedHolders
Q4 20232,400$55.0K<0.1%−9,600−80.0%ReducedHolders
Q3 202312,000$200.0K<0.1%−11,700−49.4%ReducedHolders
Q2 202323,700$654.0K<0.1%−4,800−16.8%ReducedHolders
Q1 202328,500$655.0K<0.1%+13,200+86.3%AddedHolders
Q4 202215,300$166.0K<0.1%00.0%UnchangedHolders
Q3 202215,300$128.0K<0.1%00.0%UnchangedHolders
Q2 202215,300$121.0K<0.1%+2,600+20.5%AddedHolders
Q1 202212,700$300.0K<0.1%−500−3.8%ReducedHolders
Q4 202113,200$451.0K<0.1%00.0%UnchangedHolders
Q3 202113,200$233.0K<0.1%+4,400+50.0%AddedHolders
Q2 20218,800$394.0K<0.1%−1,200−12.0%ReducedHolders
Q1 202110,000$259.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.